Advancing the development and implementation of hologenomics in biological sciences

Acronym

HoloGen

Description of the granted funding

Basic biology as well as applied fields such as agrobiology, biomedicine or biotechnology are undergoing a revolution driven by the realisation that microorganisms impact virtually all biological processes. Microorganisms associated with complex organisms are no longer considered passive passengers but active crews that continuously interact with their host to shape a wide range of biological functions that play a key role in major basic and applied processes. The application of the newest high throughput molecular technologies to address such interplay has given rise to the novel field of hologenomics, which entails the joint analysis of host genomes and microbial metagenomes with the aim of understanding the impact of host-microbiota interactions in basic and applied biological processes. The DN HoloGen has been conceived to lead the development and practical implementation of hologenomics in order to gain a more comprehensive understanding of host-microbiota interactions, and their impact in both basic and applied areas with direct relevance to many of the global societal challenges. We propose to form an unprecedented multidisciplinary and scientifically sound training network by bringing together top researchers with theoretical knowledge on symbiosis biology, microbial ecology, animal evolution, animal production and biomedicine, as well as practical expertise in large- scale (meta)genomics, DNA sequence analysis, metabolomics, computational biology and biological systems modelling. We anticipate that the research results will be (i) of academic relevance through development of new analytical frameworks and understandings of host-microbiome interactions, (ii) of direct relevance to the portfolios of the industrial partners, and (iii) through these portfolios stand to benefit the European Research and Innovation community.
Show more

Starting year

2024

End year

2028

Granted funding

572 976 €
Participant
Aluke Ltd
Participant
AFEKTA TECHNOLOGIES LTD
286 488 €
Participant
CONSORCIO PARA LA EXPLOTACION DEL CENTRO NACIONAL DE ANALISIS GENOMICO (ES)
251 971.2 €
Participant
ZiBA Science Resources SL (ES)
Participant
MYBIOTICS PHARMA LTD (IL)
Participant
GENETIC ANALYSIS AS (NO)
Participant
BIOMIN HOLDING GMBH (AT)
Participant
NORSVIN SA (NO)
Participant
EWOS INNOVATION AS (NO)
Participant
NORGES MILJO-OG BIOVITENSKAPLIGE UNIVERSITET (NO)
893 246.4 €
Coordinator
THE UNIVERSITY OF BIRMINGHAM (UK)
Participant
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (UK)
Participant
UNIVERSITAT DE BARCELONA (ES)
Participant
KOBENHAVNS UNIVERSITET (DK)
603 576 €
Participant
KATHOLIEKE UNIVERSITEIT LEUVEN (BE)
262 620 €
Participant

Amount granted

2 870 878 €

Funder

European Union

Funding instrument

HORIZON TMA MSCA Doctoral Networks

Framework programme

Horizon Europe (HORIZON)

Call

Programme part
Marie Skłodowska-Curie Actions (MSCA) (11677)
Topic
MSCA Doctoral Networks 2023 (HORIZON-MSCA-2023-DN-01-01)
Call ID
HORIZON-MSCA-2023-DN-01

Other information

Funding decision number

101169005

Identified topics

microbiome, microbiology